Emgality (galcanezumab-gnlm) is a prescription medication used for the preventive treatment of migraines in adults. It works by blocking the activity of a molecule called CGRP that is involved in the development of migraines. Emgality is given by injection and comes in two strengths. It has been shown to be effective in reducing the number of monthly migraine days in clinical trials.
However, as a healthcare provider, obtaining access to Emgality enrollment forms can be time-consuming and confusing. In this article, we will provide you with access to Emgality enrollment forms and introduce you to the Emgality Shared Solutions™ Program – which provides a variety of HCP and patient resources to streamline the process of prescribing Emgality to treat patients.